8-K: Shattuck Labs Holds Annual Meeting, Approves Equity Plan Update

Shattuck Labs, Inc. announced the outcomes of its 2026 Annual Meeting of Stockholders, including the election of directors and approval of amendments to its 2020 Equity Incentive Plan.

Summary

• Shattuck Labs, Inc. held its 2026 Annual Meeting of Stockholders on May 28, 2026.
• The meeting addressed several proposals, including the election of directors, ratification of independent auditors, advisory vote on executive compensation, advisory vote on compensation frequency, and approval of an amendment and restatement of the 2020 Equity Incentive Plan.
• All director nominees were elected.
• KPMG LLP was ratified as the independent auditor.
• An advisory vote on executive compensation was held.
• The frequency of future advisory votes on executive compensation was set to annually.
• The 2020 Equity Incentive Plan was amended and restated to increase the number of shares available for issuance by 1,691,082 and extend the plan's term to March 23, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine corporate governance activities and a necessary update to an equity incentive plan, with no significant new strategic information or financial performance indicators.

Positives

• Director nominees were elected, indicating continued confidence in the board.
• The company's independent auditor, KPMG LLP, was ratified, suggesting stability in financial oversight.
• The amendment and restatement of the 2020 Equity Incentive Plan was approved, allowing for continued equity-based compensation to attract and retain talent.
• The plan was extended to March 23, 2036, providing long-term flexibility for equity awards.
• An additional 1,691,082 shares were made available under the equity incentive plan.

Negatives

• A significant number of broker non-votes (10,607,421) were recorded for the election of directors and the advisory vote on executive compensation, potentially indicating a lack of engagement from beneficial owners or their intermediaries.
• The advisory vote on executive compensation saw a notable number of votes against (4,356,199), suggesting some shareholder dissatisfaction with current compensation practices.

Risks

• The significant number of broker non-votes could indicate a lack of full shareholder engagement or potential issues with proxy voting processes.
• The opposition to executive compensation, while advisory, could signal underlying shareholder concerns about pay-for-performance alignment.

Future Outlook

The company plans to hold future advisory votes on executive compensation annually, aligning with the outcome of Proposal 4, unless the Board determines otherwise.

Management Comments

• The company plans to hold future advisory votes on executive compensation annually until the next required vote on the frequency of such advisory votes, or until the Board of Directors of the Company otherwise determines that a different frequency is in the best interests of the Company and its stockholders.

Industry Context

StockSavvy.ai notes that the approval of equity incentive plans is a common practice for biotechnology and pharmaceutical companies like Shattuck Labs to attract and retain key scientific and executive talent in a competitive industry.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Approved director elections and equity plan amendments, impacting potential dilution and long-term incentive structures. Some shareholders expressed concerns regarding executive compensation.
• Employees: Benefit from the extended and enhanced equity incentive plan, providing opportunities for stock ownership and performance-based rewards.
• Management: Continues under elected directors and will be subject to annual advisory votes on compensation.

Next Steps

• Hold future advisory votes on executive compensation annually.
• Continue to utilize the Amended and Restated 2020 Equity Incentive Plan for employee compensation.

Key Dates

Recommendation

The filing details routine annual meeting outcomes and an amendment to an equity incentive plan. There is no new financial information, strategic direction, or significant operational update that would warrant a change in investment recommendation. The results are largely expected, with some shareholder dissent on executive compensation noted.

Keywords

Shattuck Labs, 8-K, Annual Meeting, Equity Incentive Plan, Stockholders, Director Election, Executive Compensation, KPMG LLP